logo
Select company
Select metric
$ 58.61MShareholders Equity
VS
Market
30
Sector
48
Industry
52
History
60
$ 2.41Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information

Ticker

CRDF

Company Name

CARDIFF ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIFF ONCOLOGY INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRDF - Equity Historical data
DateShareholders Equity
6/30/2025$ 58.61M
3/31/2025$ 70.88M
12/31/2024$ 82.95M
9/30/2024$ 49.39M
6/30/2024$ 52.39M
3/31/2024$ 60.89M
12/31/2023$ 69.74M
9/30/2023$ 77.83M
6/30/2023$ 86.58M
3/31/2023$ 96.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) Equity stands at $ 33.52M.
  • Over the past 5 years, CARDIFF ONCOLOGY INC's average Equity has been $ 93.76M.
  • The median Equity for CARDIFF ONCOLOGY INC during this period was $ 91.54M
  • CARDIFF ONCOLOGY INC reached its highest Equity over the past 5 years at $ 140.42M.
  • The lowest Equity recorded by CARDIFF ONCOLOGY INC in the same timeframe $ 33.52M

CARDIFF ONCOLOGY INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
MREO : MEREO BIOPHARMA GROUP PLC $ 54.18MAVTX : AVALO THERAPEUTICS INC $ 104.57MHUMA : HUMACYTE INC $ 4.05MCOYA : COYA THERAPEUTICS INC $ 28.31MVTGN : VISTAGEN THERAPEUTICS INC $ 56.77MABEO : ABEONA THERAPEUTICS INC $ 163.58MABVC : ABVC BIOPHARMA INC $ 7.01MLYEL : LYELL IMMUNOPHARMA INC $ 298.92MCURX : CURANEX PHARMACEUTICALS INC $ 305.43KMNPR : MONOPAR THERAPEUTICS $ 52.2M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

CRDF - Shareholders Equity, Last 5 years

$ 33.52M

Minimum

Sep 30, 2020

$ 140.42M

Maximum

Dec 31, 2021

$ 93.76M

Average

$ 91.54M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384.64M with a standard deviation of $ 549.08M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384.64M
median$ 166.2M
std$ 549.08M